E-LIB Suche - Ergebnisse für: Grobler, Jay A.

1

Correction to: Virologic Outcomes with Molnupiravir in Nonh..:

Strizki, Julie M. ; Grobler, Jay A. ; Murgolo, Nicholas...
Infectious Diseases and Therapy. 13 (2024) 5 - p. 1159-1160 , 2024

Link: https://doi.org/10.1007/..

2

No antagonism or cross-resistance and a high barrier to the..:

Diamond, Tracy L. ; Goh, Shih Lin ; Ngo, Winnie...
Antimicrobial Agents and Chemotherapy. 68 (2024) 7 - p. , 2024

Link: https://doi.org/10.1128/..

3

Respiratory virus coinfections during the COVID-19 pandemic..:

Johnson, Matthew G. ; Strizki, Julie M. ; Jensen, Erin...
Microbiology Spectrum. 12 (2024) 3 - p. , 2024

Link: https://doi.org/10.1128/..

4

Discovery of arylsulfonamides as a novel class of allosteri..:

Wang, Cheng ; Adam, Gregory C. ; Burlein, Christine...
Bioorganic & Medicinal Chemistry Letters. 89 (2023) - p. 129303 , 2023

Link: https://doi.org/10.1016/..

5

Virologic Outcomes with Molnupiravir in Non-hospitalized Ad..:

Strizki, Julie M. ; Grobler, Jay A. ; Murgolo, Nicholas...
Infectious Diseases and Therapy. 12 (2023) 12 - p. 2725-2743 , 2023

Link: https://doi.org/10.1007/..

6

Molnupiravir for the treatment of COVID-19 in immunocomprom..:

Johnson, Matthew G. ; Strizki, Julie M. ; Brown, Michelle L....
Infection. 51 (2023) 5 - p. 1273-1284 , 2023

Link: https://doi.org/10.1007/..

7

153. Molnupiravir Exhibits a High Barrier to the Developmen..:

Strizki, Julie ; Murgolo, Nicholas ; Gaspar, John...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

8

543. Molnupiravir Maintains Antiviral Activity Against SARS..:

Grobler, Jay ; Strizki, Julie ; Murgolo, Nicholas...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S373-S373 , 2021

Link: https://doi.org/10.1093/..

9

Generation of SARS-CoV-2 reporter replicon for high-through..:

He, Xi ; Quan, Shuo ; Xu, Min...
Proceedings of the National Academy of Sciences. 118 (2021) 15 - p. , 2021

Link: https://doi.org/10.1073/..

10

Safety and pharmacokinetics of islatravir subdermal implant..:

Matthews, Randolph P. ; Patel, Munjal ; Barrett, Stephanie E....
Nature Medicine. 27 (2021) 10 - p. 1712-1717 , 2021

Link: https://doi.org/10.1038/..

11

Impact of HIV-1 Resistance-Associated Mutations on Suscepti..:

Asante-Appiah, Ernest ; Lai, Johnny ; Wan, Hong...
Antimicrobial Agents and Chemotherapy. 65 (2021) 12 - p. , 2021

Link: https://doi.org/10.1128/..

12

Safety, tolerability, and pharmacokinetics of single‐ and m..:

Matthews, Randolph P. ; Ankrom, Wendy ; Friedman, Evan...
Clinical and Translational Science. 14 (2021) 5 - p. 1935-1944 , 2021

Link: https://doi.org/10.1111/..

13

Letter to the Editor in Response to Zhou et al:

Troth, Sean ; Butterton, Joan ; DeAnda, Carisa Stadlman...
The Journal of Infectious Diseases. 224 (2021) 8 - p. 1442-1443 , 2021

Link: https://doi.org/10.1093/..

14

Safety and Pharmacokinetics of Once-Daily Multiple-Dose Adm..:

Matthews, Randolph P. ; Jackson Rudd, Deanne ; Zhang, Saijuan...
JAIDS Journal of Acquired Immune Deficiency Syndromes. 88 (2021) 3 - p. 314-321 , 2021

Link: https://doi.org/10.1097/..

15

511. Treatment with Molnupiravir in the MOVe-In and MOVe-Ou..:

Strizki, Julie ; Grobler, Jay ; Zhang, Ying...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S357-S358 , 2021

Link: https://doi.org/10.1093/..